Mitsubishi UFJ Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-44
Closed -$13.8K 1583
2023
Q4
$13.8K Hold
44
﹤0.01% 1105
2023
Q3
$7.44K Buy
+44
New +$8.27K ﹤0.01% 1146

Other funds holding KRTX

Mitsubishi UFJ Asset Management's KRTX Position: Q1 2024 in Review

Mitsubishi UFJ Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 44 shares — an estimated $13.8K sold.

Mitsubishi UFJ Asset Management first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $13.8K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Mitsubishi UFJ Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 44 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $13.8K.
  • Mitsubishi UFJ Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Mitsubishi UFJ Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $13.8K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2024, filed 9 May 2024.